Literature DB >> 26255881

Antidotes to coumarins, isoniazid, methotrexate and thyroxine, toxins that work via metabolic processes.

D Nicholas Bateman1, Colin B Page2,3.   

Abstract

Some toxins cause their effects by affecting physiological processes that are fundamental to cell function or cause systemic effects as a result of cellular interaction. This review focuses on four examples, coumarin anticoagulants, isoniazid, methotrexate and thyroxine from the context of management of overdose as seen in acute general hospitals. The current basic clinical pharmacology of the toxin, the clinical features in overdose and evidence base for specific antidotes are discussed. The treatment for this group is based on an understanding of the toxic mechanism, but studies to determine the optimum dose of antidote are still required in all these toxins except thyroxine, where treatment dose is based on symptoms resulting from the overdose.
© 2015 The British Pharmacological Society.

Entities:  

Keywords:  antidotes; coumarin anticoagulant; isoniazid; methotrexate; poisoning; thyroxine

Mesh:

Substances:

Year:  2015        PMID: 26255881      PMCID: PMC4767197          DOI: 10.1111/bcp.12736

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  69 in total

1.  Possible adverse reactions to preservatives in high-dose pyridoxine hydrochloride i.v. injection.

Authors:  Anthony M Burda; Todd Sigg; Michael Wahl
Journal:  Am J Health Syst Pharm       Date:  2002-10-01       Impact factor: 2.637

2.  Unintentional pediatric superwarfarin exposures: do we really need a prothrombin time?

Authors:  M E Mullins; C L Brands; M R Daya
Journal:  Pediatrics       Date:  2000-02       Impact factor: 7.124

3.  Prolonged coagulopathy related to superwarfarin overdose.

Authors:  Sanjay Sarin; Hamid Mukhtar; Mohd A Mirza
Journal:  Ann Intern Med       Date:  2005-01-18       Impact factor: 25.391

4.  "Superwarfarin" (bromodialone) poisoning in two children resulting in prolonged anticoagulation.

Authors:  M C Greeff; O Mashile; L G MacDougall
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

5.  Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels.

Authors:  Naren Gunja; Andrew Coggins; Sergei Bidny
Journal:  Clin Toxicol (Phila)       Date:  2011-06       Impact factor: 4.467

6.  Isoniazid overdose.

Authors:  W M Cameron
Journal:  Can Med Assoc J       Date:  1978-06-10       Impact factor: 8.262

7.  Warfarin overdose: a 25-year experience.

Authors:  Michael Levine; Anthony F Pizon; Angela Padilla-Jones; Anne-Michelle Ruha
Journal:  J Med Toxicol       Date:  2014-06

8.  Reversal of prolonged isoniazid-induced coma by pyridoxine.

Authors:  J Brent; N Vo; K Kulig; B H Rumack
Journal:  Arch Intern Med       Date:  1990-08

Review 9.  Intentional overdosage with isoniazid: case report and review of literature.

Authors:  D Y Tai; J K Yeo; P C Eng; Y T Wang
Journal:  Singapore Med J       Date:  1996-04       Impact factor: 1.858

10.  Acute, unintentional pediatric brodifacoum ingestions.

Authors:  Greene Shepherd; Wendy Klein-Schwartz; Bruce D Anderson
Journal:  Pediatr Emerg Care       Date:  2002-06       Impact factor: 1.454

View more
  3 in total

Review 1.  Antidotes to coumarins, isoniazid, methotrexate and thyroxine, toxins that work via metabolic processes.

Authors:  D Nicholas Bateman; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2015-10-24       Impact factor: 4.335

2.  Warfarin Overdose in an Adolescent Not Dependent on Anticoagulation: Reversal Strategy and Kinetics.

Authors:  C James Watson; Michael D Simpson; James D Whitledge; Al Patterson; Michele M Burns
Journal:  J Med Toxicol       Date:  2022-09-06

Review 3.  Who gets antidotes? choosing the chosen few.

Authors:  Nicholas A Buckley; Andrew H Dawson; David N Juurlink; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2016-02-17       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.